Paper17417841
Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design.
Sturm MB and 2 others. J Am Chem Soc, 2007. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design. Papers, record 17417841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417841
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Circular | Major topic |
| RNA | Major topic |
| Ricin | Major topic |
| Cyclization | |
| Drug Design | |
| Kinetics | |
| Nucleic Acid Hybridization | |
| Oligonucleotides | |
| Oximes | |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA072444 | NCI NIH HHS | United States | R01CA072444 | PubMed and NIH |
| CA72444 | NCI NIH HHS | United States | R01CA072444 | PubMed and NIH |
Source NIH RePORTER
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,896,793 | The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. | Exp Cell Res | 2000 | https://conductscience.org/library/papers/10896793 | PubMed |
| 2 | 15,766,271 | Ricin A-chain activity on stem-loop and unstructured DNA substrates. | Biochemistry | 2005 | https://conductscience.org/library/papers/15766271 | PubMed |
| 3 | 11,596,939 | Highly efficient synthesis of peptide-oligonucleotide conjugates: chemoselective oxime and thiazolidine formation. | Chemistry | 2001 | https://conductscience.org/library/papers/11596939 | PubMed |
| 4 | 12,370,937 | Efficient and simple solid-phase synthesis of short cyclic oligodeoxynucleotides bearing a phosphorothioate linkage. | Angew Chem Int Ed Engl | 2002 | https://conductscience.org/library/papers/12370937 | PubMed |
| 5 | 14,575,507 | Head-to-tail oxime cyclization of oligodeoxynucleotides for the efficient synthesis of circular DNA analogues. | J Org Chem | 2003 | https://conductscience.org/library/papers/14575507 | PubMed |
| 6 | 15,109,249 | Ricin A-chain substrate specificity in RNA, DNA, and hybrid stem-loop structures. | Biochemistry | 2004 | https://conductscience.org/library/papers/15109249 | PubMed |
| 7 | 15,109,250 | Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state. | Biochemistry | 2004 | https://conductscience.org/library/papers/15109250 | PubMed |
| 8 | 3,571,242 | The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. | J Biol Chem | 1987 | https://conductscience.org/library/papers/3571242 | PubMed |
| 9 | 3,288,622 | The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3288622 | PubMed |
| 10 | 1,379,305 | Ribosomal RNA identity elements for ricin A-chain recognition and catalysis. Analysis with tetraloop mutants. | J Mol Biol | 1992 | https://conductscience.org/library/papers/1379305 | PubMed |
| 11 | 7,544,462 | Synthesis, deprotection, analysis and purification of RNA and ribozymes. | Nucleic Acids Res | 1995 | https://conductscience.org/library/papers/7544462 | PubMed |
| 12 | 9,000,624 | A network of heterogeneous hydrogen bonds in GNRA tetraloops. | J Mol Biol | 1996 | https://conductscience.org/library/papers/9000624 | PubMed |
| 13 | 9,037,714 | Ricin A-chain structural determinant for binding substrate analogues: a molecular dynamics simulation analysis. | Proteins | 1997 | https://conductscience.org/library/papers/9037714 | PubMed |
| 14 | 9,383,473 | Synthesis and biochemical evaluation of RNA containing an intrahelical disulfide crosslink. | Chem Biol | 1995 | https://conductscience.org/library/papers/9383473 | PubMed |
| 15 | 9,711,915 | Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma. | Leuk Lymphoma | 1998 | https://conductscience.org/library/papers/9711915 | PubMed |
| 16 | 9,708,998 | Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors. | Biochemistry | 1998 | https://conductscience.org/library/papers/9708998 | PubMed |
| 17 | 9,876,120 | Free energy determinants of binding the rRNA substrate and small ligands to ricin A-chain. | Biophys J | 1999 | https://conductscience.org/library/papers/9876120 | PubMed |
| 18 | 10,097,145 | Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10097145 | PubMed |
| 19 | 11,259,830 | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11259830 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,828,800 | Biological Nanoscaffolds from Hierarchical Construction to Applications. | Molecules | 2026 | https://conductscience.org/library/papers/41828800 | PubMed |
| 39,525,953 | Synthetic circRNA therapeutics: innovations, strategies, and future horizons. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39525953 | PubMed |
| 36,729,328 | Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context. | BioDrugs | 2023 | https://conductscience.org/library/papers/36729328 | PubMed |
| 35,390,188 | Isomorphic Fluorescent Nucleosides Facilitate Real-Time Monitoring of RNA Depurination by Ribosome Inactivating Proteins. | Chemistry | 2022 | https://conductscience.org/library/papers/35390188 | PubMed |
| 32,428,396 | Small Molecule Inhibitors Targeting the Interaction of Ricin Toxin A Subunit with Ribosomes. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32428396 | PubMed |
| 30,335,982 | Enzymatic Transition States and Drug Design. | Chem Rev | 2018 | https://conductscience.org/library/papers/30335982 | PubMed |
| 30,023,541 | Iminosugars Spiro-Linked with Morpholine-Fused 1,2,3-Triazole: Synthesis, Conformational Analysis, Glycosidase Inhibitory Activity, Antifungal Assay, and Docking Studies. | ACS Omega | 2017 | https://conductscience.org/library/papers/30023541 | PubMed |
| 29,049,877 | Synthesis of 5'-Thio-3'-O-ribonucleoside Phosphoramidites. | J Org Chem | 2017 | https://conductscience.org/library/papers/29049877 | PubMed |
| 27,823,883 | Oligonucleotide transition state analogues of saporin L3. | Eur J Med Chem | 2017 | https://conductscience.org/library/papers/27823883 | PubMed |
| 27,668,458 | In vitro circularization of RNA. | RNA Biol | 2017 | https://conductscience.org/library/papers/27668458 | PubMed |
| 26,886,255 | Transition State Structure of RNA Depurination by Saporin L3. | ACS Chem Biol | 2016 | https://conductscience.org/library/papers/26886255 | PubMed |
| 26,478,835 | Advanced Developments in Cyclic Polymers: Synthesis, Applications, and Perspectives. | ChemistryOpen | 2015 | https://conductscience.org/library/papers/26478835 | PubMed |
| 26,091,305 | Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity. | Biochemistry | 2015 | https://conductscience.org/library/papers/26091305 | PubMed |
| 23,259,601 | Transition States, analogues, and drug development. | ACS Chem Biol | 2013 | https://conductscience.org/library/papers/23259601 | PubMed |
| 22,347,620 | Inhibitors of the cellular trafficking of ricin. | Toxins (Basel) | 2012 | https://conductscience.org/library/papers/22347620 | PubMed |
| 21,689,934 | Profiling base excision repair glycosylases with synthesized transition state analogs. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21689934 | PubMed |
| 21,455,295 | Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach. | PLoS One | 2011 | https://conductscience.org/library/papers/21455295 | PubMed |
| 19,920,175 | Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19920175 | PubMed |
| 19,764,816 | Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein. | Biochemistry | 2009 | https://conductscience.org/library/papers/19764816 | PubMed |
| 18,683,267 | A highly emissive fluorescent nucleoside that signals the activity of toxic ribosome-inactivating proteins. | Angew Chem Int Ed Engl | 2008 | https://conductscience.org/library/papers/18683267 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17417841
GET https://conductscience.org/api/papers/v1/17417841/authors